Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study
暂无分享,去创建一个
R. Stupp | R. Stahel | M. Tötsch | D. Betticher | R. Schmid | H. Ris | W. Weder | A. Roth | M. Furrer | T. Cerny | M. Pless | A. Spiliopoulos | S. Hsu Schmitz | J. Habicht | E. Hansen | M. Wernli | M. Pless | H. Honegger | C. von Briel | A. Roth | F. Egli | C. Joss | M. Tötsch | Bern Switzerland for the Swiss Group for Clinical Cancer Research | S-F Hsu Schmitz | M. Tötsch | C. Joss | R. A. Schmid | J. Habicht | A. Spiliopoulos | R. Stahel | W. Weder | F. Egli | M. Furrer | H. Honegger | M. Wernli | T. Cerny | H-B. Ris | Bern Switzerland for the Swiss Group for Clinical Cancer Research